Terns Pharmaceuticals : Announces Appointment of Radhika Tripuraneni, M.D., M.P.H. to Board of Directors - Form 8-K

Terns Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases such as non-alcoholic steatohepatitis...

Related Keywords

United States ,Sen Sundaram ,Radhika Tripuraneni ,Terns Pharmaceuticals Inc ,Affairs At Synageva Biopharma Corp ,Company Nasdaq ,Research Partners ,Beth Israel Deaconess Medical Center ,Gilead Sciences Inc ,Terns Pharmaceuticals ,University Of Missouri ,Harvard University ,Genzyme Corporation ,Master In Public Health ,Company Board Of Directors ,Alexion Pharmaceuticals Inc ,Myokardia Inc ,Berry Company Public Relations ,Prothena Corporation ,Terns Announces Appointment ,Chief Development Officer ,Terns Board ,Chief Executive Officer ,Vice President ,Medical Affairs ,Chief Medical Officer ,Synageva Biopharma ,Gilead Sciences ,Summer Street Research Partners ,Public Health ,Israel Deaconess Medical ,Annual Report ,Quarterly Report ,